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THREE-DIMENSIONAL CO-CULTUIUC 
PROCESS 
OFUGIN OF THE INVENTION 
The invention described herein was made in the perfor- 
mance of work under NASA contract and is subject to 
provisions of Section 305 of the National Aeronautics and 
Space Act of 1958, Public Law 85-568 (72 Stat. 435; 42 
U.S.C. 2457). 
ms application is a divisional of U,S. application ser. 
No. 07/939,791. filed Sep. 3, 1992, now U.S. Pat. No. 
5,308,764, which is a continuation of U.S. patent application 
Ser. No. 07/317,931 filed Mar. 2, 1989, now U.S. Pat. No. and Other Of rnammah 
5,153,132, which is a continuation in part of U.S. application 15 
Ser. No. 07/213,558, filed Jun. 30, 1988, now U.S. Pat. No. 
5,026,650, and a continuation-in-part of U.S. application 
4,988,623. a l l  of which are specifically incorporated as fully 
set forth herein. 
FlELD OF THE INVENTION 
The process of the present invention relates to a 
3-dimensional coculture process. By the process of the 
present invention a variety of cells may be co-cultured to 
produce tissue which has 3-dimensionali@ and had some Of 
the characteristics of in vivo tissue. The process provides 
enhanced 3 -dimensional tissue which creates a multicellular 
organoid differentiation model. 
driven so that the moving parts within a vessel cause 
agitation in  the fluid medium for the suspension of the 
microcarrier beads and attached cells. Agitation of mamma- 
lian cells, however, subjects them to high degrees of shear 
5 stress which can damage the cells and limits ordered assem- 
bly of these cells according to cell derived energy. These 
shear stresses arise when the fluid media has significant 
relative motion with respect to vessel walls, impellers, or 
other vessel components. Cells may also be damaged in 
bio-reactor vessels with internal moving parts if the cells or 
beads with cells attached collide with one another or vessel 
components* 
bio-reactors 
‘an cells are also 
very limited in their ability to provide conditions which 
allow cells to assemble into tissues which simulate the 
three-dimensional of tissues in the intact 
organism. Conventional tissue culture processes limit, for 
a highly functionally specialized or differentiated state con- 
20 sidered crucial for mammall ‘an cell differentiation and secre- 
tion of specialized biologically active molecules of research 
and. pharmaceutical interest. Unlike microorganisms, the 
cells Of hi&er Organisms uch as mammals form 
into high order multicellular tissues. Although the exact 
25 mechanisms of this self-assembly are not known, in the 
cases that have been studied thus far, development of cells 
into tissues has been found to be dependent on orientation of 
the cells with respect to each other (the Same or 
of cell) or other anchorage subsme andlor the presence 
or absence of certain substances (factors) such as hormones, 
’ 
10 
In addition to the drawbacks Of 
ser. NO. 07/213,559, filed Juri. 30,1988, now US- pat. NO* saar reasons, the capacity for tissues to express 
BACKGROUND OF THE INVENTION 
Cell culture processes have been developed for the growth 
of single cell bacteria, yeast and molds which are resistant 
to environmental stresses or are encased with a tough cell 
wall. Mammalian cell culture, however, is much more 
complex because such cells are more delicate and have more 
complex nutrient and other environmental requirements in 
order to maintain viability and cell growth. Large scale 
culture of bacterial type cells is highly developed and such 
culture processes are less demanding and are not as difficult 
to cultivate as manunah ‘an cells. These techniques are highly 
_.” 
autocrines. or paracrines. ~n si&, no conventional 
culture process is capable of simultaneously achieveing 
sufficiently low shear stress, sufficient 3-dimensional spacial 
freedom, and sufFciently long periods for critical cell inter- 
35 actions (with each other or substrates) to allow excellent 
modeling of in vivo tissue structure. 
Paper entitled: ‘The Clhostat-A Tool For Analyzing 
The Influence of Acceleration On Solid-Liquid Systems” by 
W. Briegleb, published by the proceedings of a workshop on 
40 Space biology. cologne Germany, on Mar. 11, 1983, 
(ESASP-206, May 1983). In this paper, clinostat principals 
are described and analyzed relative to gravity affects. Some 
empirical and a lirm theoretical basis is not developed. clinostat experiments are described including experiments 
Bacterial cells can be grown in large volumes of liquid where monocellular suspended organisms (protozoans) are 
medium and can be vigorously agitated without any signifi- 45 place within cylinders which are rotated about a horizontal 
cant damage. Mammalian cells, on the other hand, cannot axis. 
withstand excessive turbulent action without damage to the A paper entitled, ‘The Large-Scale Cultivation of Mam- 
cells and must be provided with a complex nutrient medium malian Cells”, by Joseph Feder and William R. T0lba-t. 
to support growth. published in the Scientific American, Januag 1983, Vol. 
In addition. mammalian cells have other special 50 248, No. 1. pps. 36-43. In this paper, agitation of the cells 
requirements, in particular most cells must attach is described as required to keep the cells suspended in the 
themselves to some substrate surface to remain viable and to medium and describes a turbine agitator, a marine propeller 
duplicate. On a s m a l l  scale, mammalian cells have been agitator, and a vibro mixer for mixing. The paper also 
grown in containers with s m a l l  microwells to provide sur- describes a perfusion reactor in  which an agitation is pro- 
face anchors for the cells. However, cell culture processes 55 vided by four slowly rotating flexible sheets of monofila- 
‘an cells in such microwell containers generally ment nylon which are rotated about a vertical axis while the 
an medium in the main vessel is continuously pumped to the 
for mammah 
does not provide sufticient surface area to grow mammali 
cells on a sufficiently large scale basis for many commercial satellite filter vessel. The filter retains the cells which are 
or research applications. To provide greater surface areas, pumped along with the r e e d e r  medium back into the 
microcarrier beads have been developed for providing 60 vessel for further proHeration. 
increased surface areas for the cultured cells to attach. A paper entitled, “Gravisensitivity of the Acellular, Slime, 
Microcarrier beads with attached cultured cells require agi- Mold, Physarum, Polycephalum Demonstrated on the Fast 
tation in a conventional bio-reactor vessel to provide sus- Rotating Clhostat”, by Ingrid Block and Wolfgang Brigley, 
pension of the cells, distribution of fresh nutrients, and published in the European Journal of Cell Biology 41, pps. 
removal of metabolic waste products. To obtain agitation, 65 44-50, 1986. This paper described rotation of a culture 
such bio-reactor vessels have used internal propellers or vessel about a horizontal axis for the simulation of weight- 
movable mechanical agitation devices which are motor lessness. 
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Paper entitled “Cell and Environment Interactions in substrates) increase in size as the culture progresses neces- 
Tumor Microregions: The Multicell Spheroid Model”. by sitating appropriate adjustment of rotational rates with 
Robert M. Sutherland, Science 240: 177-184, (1988) dis- respect to vessel dimensions, external gravitational strength, 
closes the use of multicell spheroids, without attachment and absolute sedimentation rate through the media in Order 
substrates, of tumor cells to study cell and environment 5 to optimize these Particle Paths. Increased external gravity 
interactions in tumors. Conventional culture processes are field strength and increased tissue (and substrate) sedimen- 
utilized to produce limited size and viability tumor cell tation rate induce restrictions on the choice of parameters 
aggregates. which ultimately limits the useful operating range of the 
bio-reactors, including a slow process. These same factors place a lower limit on the shear 
cells were presented at a poster session at the First Canadian due to gravitationally induced drift Of the particles 
Workshop on R & D opportunities on Board the space the culture media. Calculations and measurements place this 
Station, National Research Council Canada. May 64,1987, to that resulting from the 
bound ’$3797 as a paper entitled “Growth and Maintenace of 15 the external gravity field strength. Centrifugal and C O r i O l ~ S  
Anchorage Dependent Cells in Zero Headspace Bioreactor induced motion along with effects due to particle 
Systems Designed For Microgravity”, by Lewis et al. and fluid interactions act to further degrade the shear stress 
level as the growing tissue increases i n  size. 
tiated Cells” by Lola M. Reid and Douglas M. Jefferson, 2o and tissues is optimized by selecting vessel dimensions and 
hepatology Vol. 4 No. 3 pp 548-560 (1984) discloses limited rotational rates which minimize collisions of the cultured techniques for the coculturing of haepatocytes and other particles with vessel walls or internal components. Again, differentiated cells. The techniques disclosed in the paper increased gravity and particle sedimentation rate (which is 
restricted in their 3-dimensional aspect and cocultured with 25 restrictions to the process operating range in tams of 
fibroblasts moderately to cocultivate differentiated layers of maintaining 3-dimensional freedom. The particular paths tissue. These techniques do not permit macroscopic inspec- which result from rotation of cells. tissues, and substrates tion of the tissue being cultured as a result of the limited size about an axis nearly papendicular to gravity results in these 
particles, which may mer greatly in sedimentation rates, to of the resulting tissue. 
localized in regions for extended 
sion” by Eileen A. Friedman Seminars in Surgical Oncology of time. mS allows these particles sacient ime to 
3:171-173 (Igg7) a for use Of interact as necessary to formmulti-cellular structures and to 
2-dimensional cocultivation to study the destructive “pa- 
bility of colon carcinoma cells when exposed to n o d  which may mer in sedimen- 
adenoma cells. This destructive capability is further 35 taion is degraded by increasing gravity and by 
enhanced by tumor promoters which stimulate the two cell increasing particle sedimentation rate. ~n all three cases; 
activity. Minimizing fluid shear stress, maintaining 3-dimensional 
freedom for spatial orientation, and maximizing spatial 
approximation of particles with difFering sedimentation SUMMARY OF THE INVENTION 
The process of the present invention is directed to 40 properties we observe a degradation of performance with 
co-culturing cells to produce multicellular organoid tissue. increasing external gravitational field strength and with 
The process forms and maintanis 3-dimensional tissue of increasing particle sedimentation rate. This then forms the 
such a size as to create a multicellular organoid differentia- basis for further enhancement of this process in a reduced 
tion model. Combinations of cells of a wide variety may be gravity environment. These three criteria then form the basis 
cultured and maintained so that differentiation and 45 for optimization of the culture environment. This process 
de-differentiation may be studied. provides the necessary means for support of respiratory gas 
exchange, supply of nutrients, and removal of metabolic 
waste products. This is accomplished either by perfusion of DGTAILED DESCRIPTION OF THE 
INVENTION media through an external media perfusion loop, direct 
The co-culturing process of the present invention opti- 50 injection to the culture media, or exchange of these mol- 
mizes a group of culture environmental conditions. even as ecules across a diffusion membrane. 
the culturing progresses, in a manner which greatly This cell and tissue culture process provides a stabilized 
enhances the capability to form and maintain 3-dimensional environment into which cells or tissues may be introduced, 
living tissue from either dissociated source cells or intact suspended, assembled, grown, and maintained with reten- 
tissue resections. The 3-dimensional living tissues are 55 tion of delicate 3-dimensional structural integrity. The fluid 
formed and maintained from cells, which is used herein to culture media is initially stabilized into near solid body 
include cells in any form, for example, individual cells or horizontal rotation within the confines of a similarly rotating 
tissue or dissociated source cells or cells preattached to vessel wall. The slowest RPM is chosen which will be 
substrate or intact tissue resections. The process simulta- suEcient to produce acceptable particle orbits (with respect 
neously minimizes the fluid shear stress, provides 60 to the 3 criteria stated in the previous paragraph) upon 
3-dimensional freedom for spatial orientation. and extends addition of the initial priming load of cells, tissue, and 
localization of cells, tissues, and substrates in a similar substrates. In most cases the initial particles with which the 
spatial region for the duration of the cell culture. Transient culture is primed sediment at a slow rate under 0.1 centi- 
disruptions of this stabilized environment are permitted and meter per second. It is therefore possible to select from a 
well tolerated for logistical purposes during initial system 65 broad range of rotational rates (typically 5 to 120 RPM) or 
priming. sample acquisition, system maintenance. and cul- vessel diameters (typically 0.5 to 36 inches). The slowest 
ture termination. The cultured 3-dimensional tissues (and rotational rate is advantageous because it minimizes equip- 
cell cultures from 
turning lateral vessel (mv)  designed for batch culture of 10 stress obtainable even within the process Operating range 
shear stress 
Ottawa. Canada, and published in the Proceedings ‘‘Space- Particles terminal velocity (through the culture media) for 
“Culturing and Other Differen- 3-bensionality for orientation of cells, substrates, 
make use of this floating collagen gels. which are severely propoAonal to in all in our experience) 
Paper entitled ‘Tissue Culture Model of Adenoma Inva- 3o re-n 
with each other. me ability to retain this 
of 
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ment wear and other logistics associated with handling of 15. The experiment is terminated when the factors in Item 13 
the culture. A vessel diameter is chosen which has the are reached and/or when cellular metabolism in the STLV 
appropriate volume for the intended quantity of cultured because too demanding to keep up with on a daily basis. 
material and which will allow a sufficient s e e b g  density of The forgoing protocol of the STLV is only one bio-reactor 
cells, tissues, and substrates for the availability of these 5 device as a specific example which may be used to carry out 
components. the process of the present invention. As specifically set forth 
The following is an exemplary protocol for forming and herinabove the process of coculturing may be carried out in  
maintaining a multicellular organoid tissue in a slow turning the rotating wall perfusedvessel (RWPV) which is described 
lateral vessel (STLV): in the parent application. 
1. An STLV is prepared by tissue culture washing and 10 
2. The s t d e ,  cooled vessel is placed in a Laminar Flow 
3. Average 175 micron (Cytodex manu- 
autoclave sterilization. EXAMPLE I 
mammahan A three dimensional multicellular organoid 
cell culture was initiated in the following manner. The 
culture device, a slow turning lateral vessel (STLV), was 
Hood and is stood upright. 
factured by p h m c i a )  are hydrated and sterilized before l5 prepare2 by washing with a tissue culture detergent, 
hand and diluted into a 20 mg/ml solution of beads in (micr0.x) and followed by extensive nhses and soaking in 
growth n m h -  An appropriate VOlUme of this 20 mg/ml Milli Q ultra high purity water. The device was sterilized by 
solution is added to the vessel to yield a final bead autoclaving and upon cooling was rinsed for residuals with 
concentration of 5 mg/d  in the total volume of the vessel. culture growth media. The vessel was placed in a laminar 
4. The vessel is filled to all but 10% of the total volume with 20 flow hood and stood upright. Cytodex 3 ~ ~ o c a r r i e r  beads 
growth media. The growth media is dependent on the type (Pharmacia) were hydrated and sterilized before hand and 
of cells being cultured in the vessel. suspended in a 20 mg./ml. solutioo of growth media; each 
5. The valves are closed and the vessel is placed in a 37" C. mg. containing 4000 micro carriers. The vessel was filled 
humidified C02 incubator with 95% air 5% CO, to with the growth media which consisted of minimal essential 
equilibrate for 1-2 hours. The incubator surrounds the 25 medium alpha (MEM), Supplemented with insulin, 
STLV and prevents evaporation of the media from the transferrin, Selenium. (5 Ug., 10 Ug.3 5 Ug-h 
STLV system. growth factor, sodiumpyxuvate, 10% fetal calf serum, hepes 
6. Cell preparation required both mixed n o d  human colon buffer 2 gr=/litm. and penicillin and streptomycin (100 
units. 100 mg./d.). fibroblasts and human colon tumor cells to be trypsinized 
together in the ratio (g:1) and placed on ice during added to the vessel to yield a final concentration of 5 mg./ml. 
the wash procedure. mer trypsinization the correct cell of microcanier in the vessel. The vessel was then filled 
mixture is washed times with phosphate buffered within 10% of the final volume with growth media. The vessel was sealed and placed in a laminar flow C02 incu- 
bator with 95% air, 5% C02, 95% humidity at 37" C. to and suspended in the correct growth media. This final cell 
35 equilibrate for one hour. At the end of one hour, the vessel mixture is held on ice until inoculation. 
inoculated with a cell number which will yield 10 cells/ cells consisting of mixed normal human colonic fihoblas@ 
bead of the mixed cell ratio. The total number of cells (4 donors) and m - 2 9 m ,  a differentiated human 
consists of the two cell types normal human colon fibro- colon adenoacinoma. ne cells were mixed in a (9: 1) 
types are 40 ratio. After inoculation, the vessel was closed, purged of 
mixed in a r d 0  that Promotes COOperatiVe effects S e n  in remaining bubbles and replaced in the incubator. The 
the later Stages of the COCUlture Process. Each W Of vessel was equipped with a 20 ml. syringe which functioned 
microcarriers contains 4000 beads. as a compliant volume. Daily monitoriog of the growth in 
8. After inoculation the vessel is filled to volume with the the vessel was accomplished by analysis of DC02, D02, 
growth media of choice and placed in the incubator. 45 glucose, mOsm and PH. At 48 hours the growth media was 
9. Initial rotation rates of the vessel are set at 10-15 rpm. replaced for the first time and each 24-hours thereafter a 
These rotation rates suspend the single cells and beads to media change was required. These changes were required to 
initiate growth. remove toxic metabolic by-products and replenish nutrient 
10. After 24 hours, the progress of the culture is inspected levels in the vessel- Media changes Were also necessary to 
and a determination is made on the necessity for rotational 50 harvest rare growth products produced from the interaction 
of the multicellular organoid culture. On day 2 the rotation 
rate was increased from 12 to 15 RPM. At 168 hours the 
predicated on the media composition was altered to include an additional 100 mg./dl. glucose as a result of increased consumption. At 216 The growth Of the hours the glucose concentration was increased to 300 mg./dl. 
55 again due to the high rate of consumption. From 138 hours glucose, D02, DC02 and pH analysis. 
merits are made in the rotational rate Of the hours the presence of well developed multicellular organoid 
dent on the size of the cell aggregates. structures were visible. These structures took on the appear- 
ance of circular structures or pseudocrypts. The culture was 
which are oriented in a three dimensional spatid COnfigU- 60 terminated at 288 hours to be@ analysis of the well 
ration. developed cellular material contained in the vessel. The 
14. Growth h i ta t ion  occurs as the experiment progresses growth media from the vessel was harvested and placed at 
and increased rotational speed no longer sufficiently sus- -80" C. for future analysis. The cellular material was 
pen& the particles. In addition, increased rotational removed and analyzed for structural components. 
speeds above 35 rpm induces centrifugal forces which 65 The t!ee dimensional multicellular organoid tissue was 
smash the particles against the outer wall of the vessel imbedded in p a r a  blocks and cut in 10 and 20 micron 
destroying critical 3-0 spatial orientation. sections. These sections were then stained with mucicarmine 
from standard culture flash. The two cell types are mixed 30 62.5 d. Of a 20 Ill&/&. SOlUtiOll Of nliCrOCalTierS Were 
7* After equilibration and preparation the is was removed from the incubator and inoculated with 5x107 
and human tumor The 
Speed. 
ll. At 48 hours the first media change usuauy is 
and the cells being cultured. 
is monitored by cell 
12. As the culture develops from 72 hours on, m y  adjust- on the culture exhibited cell to cell organization. At 216 
depen- 
13- cell and bead aggregates form Complex cell masses 
7 
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or hematoxylin and eosin. This histological staining yielded 
the presence of microscopic cellular organization which was 
determined to be pseudo-gland formation. In addition, scan- 
ning electronmicroscopy showed definite pseudo-crypt for- 
mation and the presence of organized tubular structures. 
EXAMPLE 2 
A three dimensional multicellular organoid mammah 'an 
cell culture was initiated in the same manner as described in 
Example 1. 
After removal from the incubator for equilibration. the 
vessel was inoculated with 5.0-107 cells consisting of mixed 
normal human colon fibroblasts (4 donors) and HT-29 a 
pluripotent human adenocarcinoma of the colon. The cell 
types were mixed in a ratio of (9:l). After inoculation, the 
vessel was treated as described in Example 1. Daily moni- 
toring was accomplished as stated in Example 1. At 48-hours 
into the culture the growth media was replaced as in 
Example 1. The rotation rate was increased on Day 3 from 
10 to 14 RPM. At 167 hours into the culture the concenlra- 
tion of glucose in the media was raised from 100 to 200 
mg./dl. This was a result of the increased metabolism of the 
culture. At 264 hours into the culture the growth of the 
tissues required a second increase in glucose concentration 
to 300 mg./dl. The run was terminated at 408 hours. As in 
Example 1 the vessel materials were harvested and pro- 
cessed in a similar fashion. 
Upon processing of the tissues from this cell experiment, 
the multicellular organoid tissues expressed organized poly- 
poid structures. 
These polypoid structures were visible both microscopi- 
cally and macroscopically with the final tissue size 
approaching 1 cm. Scanning electronmicroscopy revealed 
an enhanced view of complex polypoid development. 
EXAMPLE 3 
A three dimensional multicellular organoid mammah 'an 
cell culture was initiated in the following manner. The 
culture device, a rotating wall perfused vessel (500 ml. 
Volume), was prepared by washing with a tissue culture 
detergent, (Micro-x) and followed by extensive rinses and 
soaking in Milli Q water. The device was assembled and 
then sterilized by Ethylene Oxide gas. After sterilization, the 
vessel was placed in a laminar flow bench and flushed with 
mildly acidic ultra pure Milli Q water. At the end of a 16 
hour perfusion cycle, the vessel was drained, filled with 
growth media and allowed to stand overnight at room 
temperature. The growth media consisted of minimal essen- 
tial medium alpha (h4Eh4). supplemented with insulin, 
transferrin, selenium. (5 ug., 10 ug., 5 ug.), epidermal 
growth factor. sodiumpyruvate, 10% fetal calf serum, hepes 
buffer 2 gramsfiter, and penicillin and streptomycin (100 
units, 100 mg./ml.). The following day the vessel was 
drained and refilled with fresh growth media and 2.5 grams 
of Cytodex 3 micro carriers. The vessel was placed in a CO, 
incubator with 95% air, 5% CO, and 95% humidity to 
equilibrate for two hours. After equilibration, the vessel was 
removed from the incubator and inoculated with 1 . 0 ~ 1 0 ~  
cells consisting of mixed normal human colonic fibroblasts 
(4 donors) and HT-29. a pluripotent human adenocarcinoma 
of the colon. The cell types were mixed in a (9:l) ratio. 
After inoculation the rotating wall perfused vessel was 
placed in the laminar flow incubator. The vessel was 
equipped with a 20 ml, syringe which functioned as a 
compliant volume. The initial wall, vane, and spin filter 
rotations were set at 18-20 RPM. The perfusion pump was 
left off for the fmt 9 hours of the run. At 9 hours into the 
experiment the pump rate was set at 2.5 ml./min. Daily 
monitoring of the growth in the vessel was accomplished by 
analysis of DCO,, DO,, glucose. mOsm and pH. At 48 hours 
600 ml. of fresh growth media was perfused into the vessel. 
This procedure removed any dead or non-attached cells,. At 
96-hours the vessel was perfused with 600 ml. of fresh 
growth media to remove toxic metabolic by-products and 
replenish nutrient levels. At 120-hours the in-line filter 
became clogged with debris from the rotating seals and the 
emergency bypass valve was opened. In addition, 600 ml. of 
fresh media was also perfused at this time point. At 167 
lo hours into the experiment 600 ml. of 200 mg./dl. glucose 
growth media was perfused into the vessel. 
At 192 hours into the experiment the perfusion pump rate 
was increased from 2.5 to 4.0 ml./min. and 600 ml. of fresh 
media was perfused into the vessel. The pump rate was 
l5 increased to 6 ml./min. at 216 hours and 600 rnl. of fresh 
media was perfused into the system. At 264 hours the pump 
rate was increased to 9 ml./min. and fresh media (600 ml.) 
was added to the system. At this point the glucose concen- 
tration had to be increased to 300 mg./dl. At 288 hours the 
20 pump rate was increased to 10 ml./min. and 600 ml. of 300 
mg./dl. glucose was perfused. The pump rate was increased 
to 11.5 ml./min. at 314 hours and 20 ml. of 50 mg./ml. 
glucose was added to the system. At 360 hours the pump rate 
was increased to 13 ml./min. and 600 ml. of 300 mg./dl. 
25 glucose growth media was perfused. 600 ml. of 300 mg./dl. 
glucose media was perfused at 384 hours. The experiment 
was terminated at 408 hours. From 167 hours into the 
experiment through to the end the culture exhibited 
multicellular. structural development. Polypoid formation 
3o was evident at first by light microscopy and later macro- 
scopically. The growth media was harvested from the vessel 
and placed at -80" C.  for later analysis. The multicellular 
tissue material was removed from the vessel and divided 
into samples for analysis. Analysis of the three dimensional 
organoid tissue which had been imbedded in p a r a n  and 
35 sectioned, revealed the presence of complex polypoid struc- 
tures and specific areas of cellular differentiation. These 
determinations were made by means of mucicarmine and 
hematoxylin and eosin stains. 
We claim: 
1. An artificially produced marnmah 'an organoid differen- 
tiation model comprising a three-dimensional tumor mass 
having a diameter not exceeding about 1.0 centimeter, 
wherein said three-dimensional tumor mass has a multiplic- 
ity of microcarriers which organize into said three- 
2. The artificially produced mammalian organoid differ- 
entiation model of claim 1, further comprising complex 
polypoid structures. 
3. The artificially produced mammah 'an organoid differ- 
5o entiation model of claim 1, further comprising pseudocrypt 
formations. 
4. The artificially produced - 'an organoid differ- 
entiation model of claim 1. further comprising fibroblasts 
and pluripotent human adenocarcinoma. 
5. The artificially produced mammah 'an organoid differ- 
55 entiation model of claim I, further comprising n o d  
human colon fibroblasts and human colon tumor cells. 
6. The artificially produced mammah 'an organoid differ- 
entiation model of claim 5, further comprising fibroblasts 
and tumor cells in a 9:l ratio. 
7. An artificially produced mammalian organoid differen- 
tiation model of claim 1, further comprising organized 
tubular structures. 
8. An artificially produced mammalian organoid differen- 
tiation model of claim 1, further comprising areas of cellular 
40 
45 dimensional tumor mass. 
60 
65 differentiation. 
* * * * *  
